These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6136967)

  • 1. Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.
    Selkoe DJ; Abraham C; Ihara Y
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6070-4. PubMed ID: 6136967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase and the neuronal cytoskeleton in Alzheimer's disease.
    Miller CC; Anderton BH
    J Neurochem; 1986 Jun; 46(6):1912-22. PubMed ID: 2871133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.
    Norlund MA; Lee JM; Zainelli GM; Muma NA
    Brain Res; 1999 Dec; 851(1-2):154-63. PubMed ID: 10642839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal and hair follicle transglutaminases and crosslinking in skin.
    Peterson LL; Wuepper KD
    Mol Cell Biochem; 1984; 58(1-2):99-111. PubMed ID: 6200759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular transglutaminases in neural development.
    Hand D; Perry MJ; Haynes LW
    Int J Dev Neurosci; 1993 Dec; 11(6):709-20. PubMed ID: 7907835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of tau.
    Dudek SM; Johnson GV
    J Neurochem; 1993 Sep; 61(3):1159-62. PubMed ID: 8103081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea.
    Selkoe DJ; Ihara Y; Salazar FJ
    Science; 1982 Mar; 215(4537):1243-5. PubMed ID: 6120571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase and neuronal differentiation.
    Maccioni RB; Seeds NW
    Mol Cell Biochem; 1986 Feb; 69(2):161-8. PubMed ID: 2870428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide.
    Dudek SM; Johnson GV
    Brain Res; 1994 Jul; 651(1-2):129-33. PubMed ID: 7922559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.
    Nukina N; Kosik KS; Selkoe DJ
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3415-9. PubMed ID: 3106969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of brain substrates of transglutaminase by functional proteomics supports its role in neurodegenerative diseases.
    André W; Nondier I; Valensi M; Guillonneau F; Federici C; Hoffner G; Djian P
    Neurobiol Dis; 2017 May; 101():40-58. PubMed ID: 28132929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel inhibitors against the transglutaminase-catalysed crosslinking of lens proteins.
    Lorand L; Stern AM; Velasco PT
    Exp Eye Res; 1998 May; 66(5):531-6. PubMed ID: 9628800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells.
    Chowdhury ZA; Barsigian C; Chalupowicz GD; Bach TL; Garcia-Manero G; Martinez J
    Exp Cell Res; 1997 Feb; 231(1):38-49. PubMed ID: 9056410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three different human tau isoforms and rat neurofilament light, middle and heavy chain proteins are cellular substrates for transglutaminase.
    Grierson AJ; Johnson GV; Miller CC
    Neurosci Lett; 2001 Jan; 298(1):9-12. PubMed ID: 11154823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue transglutaminase in Alzheimer's disease: involvement in pathogenesis and its potential as a therapeutic target.
    Wilhelmus MM; de Jager M; Bakker EN; Drukarch B
    J Alzheimers Dis; 2014; 42 Suppl 3():S289-303. PubMed ID: 24685636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase activity is increased in Alzheimer's disease brain.
    Johnson GV; Cox TM; Lockhart JP; Zinnerman MD; Miller ML; Powers RE
    Brain Res; 1997 Mar; 751(2):323-9. PubMed ID: 9099822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase.
    El Nahas AM; Abo-Zenah H; Skill NJ; Bex S; Wild G; Griffin M; Johnson TS
    Nephron Clin Pract; 2004; 97(3):c108-17. PubMed ID: 15292688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the intrinsic transglutaminase in the Ca2+-mediated crosslinking of erythrocyte proteins.
    Lorand L; Weissmann LB; Epel DL; Bruner-Lorand J
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4479-81. PubMed ID: 12508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis.
    Johnson TS; Griffin M; Thomas GL; Skill J; Cox A; Yang B; Nicholas B; Birckbichler PJ; Muchaneta-Kubara C; Meguid El Nahas A
    J Clin Invest; 1997 Jun; 99(12):2950-60. PubMed ID: 9185519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.
    Perry G; Rizzuto N; Autilio-Gambetti L; Gambetti P
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3916-20. PubMed ID: 3889918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.